Curi RMB Capital LLC Lowers Stock Position in CME Group Inc. (NASDAQ:CME)

Curi RMB Capital LLC trimmed its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 36.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 82,031 shares of the financial services provider's stock after selling 46,449 shares during the quarter. Curi RMB Capital LLC's holdings in CME Group were worth $19,050,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of CME. Vanguard Group Inc. boosted its position in CME Group by 1.0% during the fourth quarter. Vanguard Group Inc. now owns 34,243,090 shares of the financial services provider's stock worth $7,952,273,000 after purchasing an additional 326,623 shares during the period. Geode Capital Management LLC grew its stake in CME Group by 1.3% in the 4th quarter. Geode Capital Management LLC now owns 8,389,442 shares of the financial services provider's stock valued at $1,946,717,000 after buying an additional 104,697 shares in the last quarter. Norges Bank purchased a new position in CME Group in the 4th quarter valued at approximately $1,107,389,000. FIL Ltd lifted its position in shares of CME Group by 1.5% during the fourth quarter. FIL Ltd now owns 4,081,391 shares of the financial services provider's stock worth $947,821,000 after acquiring an additional 61,908 shares in the last quarter. Finally, Raymond James Financial Inc. bought a new position in shares of CME Group in the fourth quarter worth $871,063,000. 87.75% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, Director Howard J. Siegel sold 10,000 shares of CME Group stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $260.00, for a total value of $2,600,000.00. Following the sale, the director now owns 21,873 shares in the company, valued at $5,686,980. The trade was a 31.37 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Hilda Harris Piell sold 3,984 shares of the business's stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $250.47, for a total transaction of $997,872.48. Following the transaction, the insider now directly owns 27,046 shares in the company, valued at approximately $6,774,211.62. The trade was a 12.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 27,076 shares of company stock valued at $6,871,496 over the last ninety days. 0.30% of the stock is owned by insiders.

CME Group Trading Down 0.8 %

CME stock traded down $2.20 during midday trading on Monday, hitting $260.33. The company had a trading volume of 2,477,098 shares, compared to its average volume of 2,146,103. The stock has a market cap of $93.81 billion, a price-to-earnings ratio of 26.92, a PEG ratio of 6.76 and a beta of 0.43. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $273.42. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The stock's 50 day moving average price is $257.42 and its 200 day moving average price is $240.90.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 EPS for the quarter, beating analysts' consensus estimates of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. As a group, equities research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th were issued a dividend of $1.25 per share. This is a positive change from CME Group's previous quarterly dividend of $1.15. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.92%. The ex-dividend date of this dividend was Friday, March 7th. CME Group's dividend payout ratio is currently 51.71%.

Analysts Set New Price Targets

A number of analysts recently issued reports on CME shares. Piper Sandler increased their price objective on CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a report on Tuesday, April 8th. JPMorgan Chase & Co. boosted their price objective on shares of CME Group from $209.00 to $212.00 and gave the company an "underweight" rating in a research note on Thursday, February 13th. Oppenheimer raised their price target on shares of CME Group from $269.00 to $279.00 and gave the company an "outperform" rating in a report on Friday, April 11th. Royal Bank of Canada reiterated a "sector perform" rating and issued a $269.00 price objective on shares of CME Group in a research report on Thursday, April 3rd. Finally, Bank of America upped their target price on CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a research note on Wednesday, April 2nd. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $247.47.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.